Predicting Determinants of Long-Term HIV Control With Gene Therapy Strategies
Gene therapy to render lymphocytes resistant to HIV infection is a proposed strategy to achieve long-term antiretroviral-free remission (e.g. CCR5 modification or delivery of antiviral gene products). Preliminary in vivo studies of gene therapy, however, have had limited success, and there is a need to elucidate the conditions under which modified cells have sufficient selective advantages to…